The detection of diverse tumor markers to lung carcinoma metastasis and prognosis evaluation
Gu Yan
Abstract
Gu Yan
Abstract
Objective:To investigate the combined detection of diverse tumor markers to lung carcinoma metastasis and the value of prognosis evaluation.Methods:The blood serum of 117 patients with lung carcinoma were detected by diverse tumor markers protein biochip for determining the level of 12 kinds of tumor markers(AFP,NSE,CEA,CA125,CA199,CA242,CA153,ferritin,free-PSA,PSA,β-HCG and HCG) in the blood,and in those cases,88 cases were identified as metastasis group and 29 as non-metastasis group,and prognosis was followed up.Results:The positive rate of metastasis group was 67.1%(59/88),which was evidently higher than the rate of non-metastasis 27.6%(8/29)(P=0.0002) ;after 2-year's follow-up,it was found that the death rate of patients with positive tumor markers was 95.31%(61/64),which was evidently higher than the negative group 55.56%(25/45)(P=0.0000).Conclusion:The combined detection of tumor markers can be used as index of clinical criterion of lung carcinoma metastasis,and that is significant to prognosis evaluation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the combined detection of diverse tumor markers to lung carcinoma metastasis and the value of prognosis evaluation.Methods:The blood serum of 117 patients with lung carcinoma were detected by diverse tumor markers protein biochip for determining the level of 12 kinds of tumor markers(AFP,NSE,CEA,CA125,CA199,CA242,CA153,ferritin,free-PSA,PSA,β-HCG and HCG) in the blood,and in those cases,88 cases were identified as metastasis group and 29 as non-metastasis group,and prognosis was followed up.Results:The positive rate of metastasis group was 67.1%(59/88),which was evidently higher than the rate of non-metastasis 27.6%(8/29)(P=0.0002) ;after 2-year's follow-up,it was found that the death rate of patients with positive tumor markers was 95.31%(61/64),which was evidently higher than the negative group 55.56%(25/45)(P=0.0000).Conclusion:The combined detection of tumor markers can be used as index of clinical criterion of lung carcinoma metastasis,and that is significant to prognosis evaluation.
Key concepts: Medicine, Metastasis, Internal medicine, Lung, Carcinoma, Tumor marker, Oncology, Pathology